Market Cap (In CAD)
61.21 Million
Revenue (In CAD)
57.26 Million
Net Income (In CAD)
6.94 Million
Avg. Volume
21.07 Thousand
- Currency
- CAD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.52-1.04
- PE
- -
- EPS
- -
- Beta Value
- 1.072
- ISIN
- CA13765U2002
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Zohar Krivorot
- Employee Count
- -
- Website
- https://cannara.ca
- Ipo Date
- 2019-01-14
- Details
- Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
More Stocks
-
TGNATEGNA Inc.
TGNA
-
TYFG
-
603993China Molybdenum Co., Ltd.
603993
-
ALSGDSpineGuard SA
ALSGD
-
BARKBARK, Inc.
BARK
-
ALFENAlfen N.V.
ALFEN
-
CPOP
-
BAMIBanco BPM S.p.A.
BAMI